Freshly Printed - allow 5 days lead
Couldn't load pickup availability
Clinical Immuno-Oncology
Understand and apply recent advances in immunology to oncology therapeutics
John E. Niederhuber (Author)
9780323877633, Elsevier Health Sciences
Hardback, published 9 June 2023
336 pages
23.4 x 15.6 x 2.4 cm, 0.48 kg
Offering focused, practical, and up-to-date content on immunotherapies used to treat a wide variety of cancer types, Clinical Immuno-Oncology covers the basic cellular and molecular mechanisms involved in cancer initiation and progression. The text reviews the development of tumor specific antigens and the challenges of developing cancer immunotherapies. Every effort is made to relate the fundamental aspects of host immunity to the efficacy of current immunotherapies and how they work in conjunction with the immune system to combat cancer. This foundational resource explains the basics of cancer immunotherapy, discusses best practices, and provides recommendations from experienced clinicians in the field. Dr. John E. Niederhuber and a team of expert contributing authors provide clinically focused information essential for integrating these new therapies into practice—making this an ideal resource for fellows, practitioners, and other cancer team members in medical oncology, radiation oncology, cancer surgery, immunology, and cancer research. Offers balanced and synthesized content on clinical science, clinical and translational research, and evidence-based practice for cutting-edge immunotherapies. Discusses clinical applications of immunotherapies in common types of cancer including melanoma, breast cancer, pancreatic cancer, colon and rectum cancer, prostate cancer, leukemias, and hematologic malignancies. Includes dedicated chapters on immune responses, innate immunity, active immunization against cancer, and cell-based therapies by leading experts. Covers key topics such as cancer immunotherapy in the presence of COVID-19, immunotherapeutics, new findings concerning the role of the microbiome in immunotherapy, advances in engineered cell-based therapies, and active immunization against cancer. An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud.
Tentative TOC: Introduction: Chapter 1.0 Development and Structure of the Lymphoid System Chapter 2.0 The Chemistry, Structure, and Function of Immunoglobulins Chapter 3.0 The Role of the Complement System in Cancer Chapter 4.0 Cancer as Non-Self 4.1 primary generator of tumor-specific transplantation type antigens 4.2 character of non-self, tumor associated antigens 4.3 immune surveillance – innate immunity 4.4 distinguishing between self and non-self 4.5 toll-like receptors (TLRs); soluble bioactive proteins such as cytokines and C’ proteins 4.6 NK cells Chapter 5.0 The Adaptive Immune Response in Cancer Chapter 6.0 The Science of Innate Immunity 6.1 critical regulator of human inflammatory disease 6.2 anatomic and physiologic barriers to pathogens – cancer causing viruses 6.3 centrally a limited number of critical receptors 6.4 the character of the inflammatory response 6.5 lack of ability to form memory 6.5 role in activating subsequent adaptive immune response Chapter 7.0 Immune Surveillance 7.1 history of concept (Ilya Mechnikov 1908 Nobel Prize) 7.2 evidence for immune surveillance today 7.3 cancer in the immunocompromised host Chapter 8.0 Cancer – Avoiding Immune Detection 8.1 cancer and the presence of immune resistance 8.2 concept for the development of tumor cell tolerance Chapter 9.0 Active Immunization Against Cancer and Cell-based Therapies 9.1 infusing in-vitro expanded Tumor Infiltrating Lymphocytes (TILs) 9.2 infusing dendritic cells pre-loaded with tumor specific oligopeptide antigens 9.3 B7 co-activating receptor 9.4 vaccines Chapter 10.0 The Three Major Clinical Components of Cancer Immunotherapy (modulating cell-mediated immune mechanisms) 10.1 the role of and application of check point blockade 10.2 the role and application of cell-based therapies including CAR-T cell therapies 10.3 antibodies (and vaccines); monoclonal antibodies and novel application of bi- or tri-specifics Chapter 11.0 The Clinical Application of Immunotherapeutics 11.1 in melanoma cancer 11.2 in breast cancer 11.3 in pancreatic cancer 11.4 in colon and rectum cancer 11.5 in prostate cancer 11.6 in leukemias and hematologic malignancies 11.7 in other malignancies Chapter 12.0 Cancer Immunotherapy in the Presence of COVID-19 12.1 immune response to coronavirus-2 infection 12.2 CD8+ T cell depression during chronic viral infection and cancer 12.3 checkpoint inhibitors in cancer patients with coronavirus infection 12.4 coronavirus depletion of CD4+ T cells
Subject Areas: Oncology [MJCL]
